Remote Patient Monitoring Sector Driving Transformational Growth through Strategic Partnerships: Forecast-Global, 2024-2028

Industry Convergence and Digitalization Intensify the Competitive Environment

Remote patient monitoring (RPM) encompasses devices and IT infrastructure designed to enable clinicians to collect and monitor patients' biometric data and behaviors remotely. This infrastructure includes software, gateways, platforms, data transmission and management systems, and networks. While consumer-grade wearables, including smartphones, smartwatches, and fitness trackers, can provide similar data (e.g., heart rate, sleep quality, mobility), this study focuses exclusively on clinician-intended RPM technologies due to their higher consistency and accuracy.

RPM differs from telehealth, which primarily involves communication via video or audio between patients and clinicians. Instead, RPM focuses on the remote collection of vital statistics, biochemistry, and cardiac rhythms, along with related products and services that transmit and provide clinical insights into the collected data. Despite the integral role of EMR/EHR technology in RPM workflows, this study excludes these technologies from market calculations, treating them as separate entities.

Many consumer-grade wearables (e.g., smartphones, smartwatches, and fitness trackers) provide data similar to devices that are part of the RPM industry (e.g., heart rate and rhythm, sleep length and quality, and mobility). However, for this analysis, we limit the definition of RPM to technologies specifically intended for use by clinicians to monitor patients. While it is possible to use consumer-grade devices in medical RPM in the future, there is a wider variance in their consistency and accuracy, so clinicians do not currently widely accept them.

This global analysis provides an overview of major markets, primarily the United States due to the greater availability of data and significant growth and innovation driven by start-ups in the region. The RPM industry is segmented by care continuum and the range of products and services offered. Companies may offer a suite of products for specific points of care or specialize in products or services with broader applications. While the differentiation among these offerings is noted, Frost & Sullivan does not provide forecasts on product segmentation, as the industry predominantly sells these products and services as bundled solutions.

The comprehensive analysis equips healthcare stakeholders with critical insights to navigate the evolving RPM landscape, highlighting growth opportunities, regional trends, and business model analyses essential for strategic decision-making.